- Filed
- Mar 25, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 17, 2026 | 8.61M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 8.61M sh |
| Shares Diluted restated | FY 2025 · Dec 31, 2024 | 8.39M sh |
| Capex | FY 2025 · Dec 31, 2025 | $23K |
| Capex | FY 2025 · Dec 31, 2024 | $19K |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$29.76M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$21.03M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $41.3M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $71.08M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $39.35M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $71.48M |
| Stockholders Equity | FY 2025 · Dec 31, 2023 | $91.02M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $8.26M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $4.97M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $8.26M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $4.97M |
| Current Assets | FY 2025 · Dec 31, 2025 | $45.62M |
| Current Assets | FY 2025 · Dec 31, 2024 | $74.46M |
| Total Assets | FY 2025 · Dec 31, 2025 | $47.61M |
| Total Assets | FY 2025 · Dec 31, 2024 | $76.44M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$4.04 |
| Eps Diluted restated | FY 2025 · Dec 31, 2024 | −$3.04 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$4.04 |
| Eps Basic restated | FY 2025 · Dec 31, 2024 | −$3.04 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $15.96M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $13.5M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $21.19M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $14.12M |
| Net Income | FY 2025 · Dec 31, 2025 | −$34.77M |
| Net Income | FY 2025 · Dec 31, 2024 | −$25.5M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$37.14M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$27.62M |